Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Nature Communications|September 4, 2015
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2Sunil J Advani, Maria Fernanda Camargo, Laetitia Seguin, et al.
Nature Medicine|November 15, 2011
A MEK-independent role for CRAF in mitosis and tumor progressionAinhoa Mielgo, Laetitia Seguin, Miller Huang, et al.
Cancer Discovery|September 13, 2017
Galectin-3, a Druggable Vulnerability for KRAS-Addicted CancersLaetitia Seguin, Maria F Camargo, Hiromi I Wettersten, et al.
Blood|January 9, 2008
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorLisette M Acevedo, Samuel Barillas, Sara M Weis, et al.
Sub-Cellular Biochemistry|April 5, 2022
KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through MacropinocytosisLaetitia Seguin
Developmental Cell|August 14, 2014
Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary glandJay S Desgrosellier, Jacqueline Lesperance, Laetitia Seguin, et al.
Cancer Research|August 17, 2019
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer ProgressionHiromi I Wettersten, Sara M Weis, Paulina Pathria, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levelsRichard J Aspinall, Sara M Weis, Leo Barnes, et al.
Blood|October 26, 2006
Cooperation between VEGF and beta3 integrin during cardiac vascular developmentSara M Weis, Jeffrey N Lindquist, Leo A Barnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2008
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasisEric A Murphy, Bharat K Majeti, Leo A Barnes, et al.
Pageof 11